Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells

Clinical and Experimental Immunology

Volumn 177, Issue 3, 2014, Pages 732-742

  Bellemore, S M ^a   Nikoopour, E ^a   Au, B C Y ^a   Krougly, O ^a   Lee Chan, E ^a   Haeryfar, S M ^a   Singh, B ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Apolipoprotein E; Atherosclerosis; Immunomodulation; Peptides; Plasmacytoid dendritic cells

Indexed keywords

APOLIPOPROTEIN E; EP1 B PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIATHEROGENIC ACTIVITY; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL PROLIFERATION; CELL SUBPOPULATION; DRUG ACTIVITY; DRUG EFFECT; EX VIVO STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE CELL; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

APOLIPOPROTEIN E; ATHEROSCLEROSIS; IMMUNOMODULATION; PEPTIDES; PLASMACYTOID DENDRITIC CELLS;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11C; APOLIPOPROTEINS E; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INJECTIONS, INTRAPERITONEAL; INTERFERON-ALPHA; MICE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; PHENOTYPE; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 84904307563     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12370     Document Type: Article

References (32)

1. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12:204-212.
2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473:317-325.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
4. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27:165-197.
5. Niessner A, Weyand CM. Dendritic cells in atherosclerotic disease. Clin Immunol 2010; 134:25-32.
6. Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev 2010; 234:45-54.
7. Guilliams M, Henri S, Tamoutounour S etal. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol 2010; 40:2089-2094.
8. Banchereau J, Briere F, Caux C etal. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
9. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5:1219-1226.
10. Matta BM, Castellaneta A, Thomson AW. Tolerogenic plasmacytoid DC. Eur J Immunol 2010; 40:2667-2676.
11. Haeryfar SM. The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation? Trends Immunol 2005; 26:311-317.
12. Björck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001; 98:3520-3526.
13. Nakano H, Yanagita M, Gunn MD. CD11c, B220, Gr-1 cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001; 194:1171-1178.
14. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 2006; 177:3260-3265.
15. Van Gool SW, Vandenberghe P, De Boer M, Ceuppens JL. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-Cell activation model. Immunol Rev 1996; 153:47-83.
16. Bocksch L, Stephens T, Lucas A, Singh B. Apolipoprotein E: possible therapeutic target for atherosclerosis. Curr Drug Targets Cardiovasc Haematol Disord 2001; 1:93-106.
17. Bocksch L, Rider BJ, Stephens T etal. C-terminal apolipoprotein E-derived peptide, Ep1.B, displays anti-atherogenic activity. Atherosclerosis 2007; 194:116-124.
18. Stephens TA, Nikoopour E, Rider BJ etal. Dendritic cell differentiation induced by a self- peptide derived from apolipoprotein E. J Immunol 2008; 181:6859-6871.
19. Daissormont IT, Christ A, Temmerman L etal. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ Res 2011; 109:1387-1395.
20. Döring Y, Zernecke A. Plasmacytoid dendritic cells in atherosclerosis. Front Physiol 2012; 3:230. doi: 10.3389/fphys.2012.00230. eCollection 2012.
21. Subramanian M, Tabas I. Dendritic cells in atherosclerosis. Semin Immunopathol 2014; 36:93-102.
22. Nikoopour E, Sandrock C, Huszarik K etal. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2·5 T cells in nonobese diabetic mice. J Immunol 2011; 186:3831-3835.
23. Nikoopour E, Cheung R, Bellemore S etal. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice. Eur J Immunol 2014; 44:1170-1180.
24. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158:2723-2730.
25. Matheu MP, Sen D, Cahalan MD, Parker I. Generation of bone marrow derived murine dendritic cells for use in 2-photon imaging. J Vis Exp 2008; 17:773-776.
26. Stadinski BD, Delong T, Reisdorph N etal. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010; 11:225-231.
27. Björck P, Leong HX, Engleman EG. Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset. J Immunol 2011; 186:1477-1485.
28. Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunol Rev 2010; 234:5-17.
29. Fogg DK, Sibon C, Miled C etal. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006; 311:83-87.
30. Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 2007; 178:7849-7858.
31. Sharma MD, Baban B, Chandler P etal. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase. J Clin Invest 2007; 117:2570-2582.
32. Ferreira GB, Gysemans CA, Demengeot J etal. 1, 25-dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice. J Immunol 2014; 192:4210-4220.